Anavasi Diagnostics develops advanced molecular diagnostic platforms for infectious disease detection. The company focuses on creating high-throughput, automated systems for clinical laboratories. Their technology aims to improve turnaround times and accuracy for pathogen identification.
Funding
$30.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current laboratory-based SARS-CoV-2 testing methods often have turnaround times that delay diagnosis and treatment decisions, especially in point-of-care settings. The need for specialized equipment and trained personnel further limits rapid access to results, hindering effective patient triage and resource allocation.
Solution
AscencioDx has developed a portable molecular diagnostic platform that enables rapid detection of SARS-CoV-2 at the point of care. The system delivers positive test results in as few as 20 minutes by analyzing samples for three specific gene targets of SARS-CoV-2, including emerging variants. This rapid detection capability allows healthcare professionals to quickly identify infections, enhancing patient triage and optimizing resource utilization in settings such as physicians' offices, urgent care clinics, and pharmacies. The device provides laboratory-grade outcomes with a user-friendly workflow, empowering clinicians with comprehensive detection capabilities for SARS-CoV-2 variants using redundant genetic targets.
Target Audience
The primary target audience includes healthcare professionals in physicians' offices, urgent care clinics, pharmacies, and other point-of-care facilities requiring rapid and accurate SARS-CoV-2 detection.
Features
- Rapid detection of SARS-CoV-2 with positive results in as few as 20 minutes
- Portable design for point-of-care testing in various medical settings
- Detection of three gene targets specific to SARS-CoV-2, including emerging variants
- Optimized probes to enhance the reliability of virus detection
- Simple and user-friendly workflow with reduced manual intervention